COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Worms and Bugs > Estimating the impact of SARS-CoV-2 lineage B.1.1.7 on mortality due to COVID-19 in the UK
Estimating the impact of SARS-CoV-2 lineage B.1.1.7 on mortality due to COVID-19 in the UKAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Dr Ciara Dangerfield. The B.1.1.7 lineage of SARS -CoV-2 was first identified in the South East of England during the Autumn of 2020. It is more transmissible than previously circulating variants and spread rapidly despite the second national lockdown in November. Over the same period hospital services were under immense pressure and the NHS was at risk of being over-whelmed. particularly in intensive care. Issues with hospital capacity are known to increase mortality. We conducted a matched cohort study to examine the independent effect of B.1.1.7 infection on mortality against this complex and shifting background of risks and biases. This talk is part of the Worms and Bugs series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsProteins, Genomes & Computers REAL Centre Slavonic Film and Media StudiesOther talksDemystifying Deep Learning Regulation of Protein Degradation in Cancer and Effect on Tumor Immunity Preserving food naturally - A talk by Meg Clarke and Jacky Sutton-Adam Computational Neuroscience Journal Club PROTAC-mediated Protein Degradation: A New Therapeutic Modality A Retrospective on the 2014 NeurIPS Experiment |